Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RISANKIZUMAB-RZAA vs RISPERDAL CONSTA: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RISANKIZUMAB-RZAA vs RISPERDAL CONSTA: Safety Overview

Metric RISANKIZUMAB-RZAA RISPERDAL CONSTA
Total FAERS Reports 65,422 140
Deaths Reported 2,269 29
Death Rate 3.5% 20.7%
Hospitalizations 14,095 56
Average Patient Age 56.5 yrs 45.0 yrs
% Female Patients 57.1% N/A
Marketing Status Prescription N/A